Value of the chlorhexidine decontamination method for recovery of nontuberculous mycobacteria from sputum samples of patients with cystic fibrosis

被引:48
作者
Ferroni, A
Vu-Thien, H
Lanotte, P
Le Bourgeois, M
Sermet-Gaudelus, I
Fauroux, B
Marchand, S
Varaigne, F
Berche, P
Gaillard, JL
Offredo, C
机构
[1] Hop Necker Enfants Malad, Microbiol Serv, Assistance Publ Hop Paris, Microbiol Lab, F-75015 Paris, France
[2] Hop Trousseau, AP HP, Microbiol Lab, F-75571 Paris, France
[3] Hop Bretonneau, Microbiol Lab, Tours, France
[4] Hop Necker Enfants Malad, AP HP, Serv Pneumol Allergol Pediat, Paris, France
[5] Hop Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France
[6] Hop Trousseau, AP HP, Serv Pneumol Pediat, F-75571 Paris, France
[7] Hop Pediat Gatien Clocheville, Serv Pediat, Tours, France
[8] Hop Bretonneau, Serv Pneumol, Tours, France
[9] Hop Ray Poincare, AP HP, Microbiol Lab, Garches, France
关键词
D O I
10.1128/JCM.00285-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The chlorhexidine method was compared to the N-acetyl-L-cysteine-NaOH-oxalic acid decontamination method currently recommended for the recovery of nontuberculous mycobacteria (NTM) from patients with cystic fibrosis. Sputum samples (n = 827) treated with chlorhexidine yielded twice as many NTM-positive cultures as those treated by the reference method (54 [6.50%] versus 27 (3.25%]; P < 0.0001) despite a higher contamination rate (20% versus 14.2%; P = 0.0017).
引用
收藏
页码:2237 / 2239
页数:3
相关论文
共 18 条
[1]   Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis [J].
Bange, FC ;
Böttger, EC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (07) :546-548
[2]   Recovery of mycobacteria from patients with cystic fibrosis [J].
Bange, FC ;
Kirschner, P ;
Böttger, EC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (11) :3761-3763
[3]   FEASIBILITY OF A COMBINED CARRIER TEST FOR DISINFECTANTS - STUDIES WITH A MIXTURE OF 5 TYPES OF MICROORGANISMS [J].
BEST, M ;
SPRINGTHORPE, VS ;
SATTAR, SA .
AMERICAN JOURNAL OF INFECTION CONTROL, 1994, 22 (03) :152-162
[4]   EFFICACIES OF SELECTED DISINFECTANTS AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
BEST, M ;
SATTAR, SA ;
SPRINGTHORPE, VS ;
KENNEDY, ME .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (10) :2234-2239
[5]  
Brown-Elliott BA, 2001, J CLIN MICROBIOL, V39, P2745, DOI 10.1128/JCM.39.7.2745-2746.2001
[6]   Measurement of immunoglobulin g against mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus [J].
Ferroni, A ;
Sermet-Gaudelus, I ;
Le Bougeois, M ;
Pierre-Audigier, C ;
Offredo, C ;
Rottman, M ;
Guillemot, D ;
Bernéde, C ;
Vincent, V ;
Berche, P ;
Gaillard, JL .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) :58-66
[7]   Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis [J].
Griffith, DE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) :810-812
[8]   NONTUBERCULOUS MYCOBACTERIA IN ADULT PATIENTS WITH CYSTIC-FIBROSIS [J].
KILBY, JM ;
GILLIGAN, PH ;
YANKASKAS, JR ;
HIGHSMITH, WE ;
EDWARDS, LJ ;
KNOWLES, MR .
CHEST, 1992, 102 (01) :70-75
[9]   Nontuberculous mycobacteria I: Multicenter prevalence study in cystic fibrosis [J].
Olivier, KN ;
Weber, DJ ;
Wallace, RJ ;
Faiz, AR ;
Lee, JH ;
Zhang, YS ;
Brown-Elliot, BA ;
Handler, A ;
Wilson, RW ;
Schechter, MS ;
Edwards, LJ ;
Chakraborti, S ;
Knowles, MR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) :828-834
[10]  
Peres PJ, 1988, REV FR LAB, V173, P67